Guardant Health, Inc. (NASDAQ:GH) Given Average Rating of “Moderate Buy” by Analysts

Shares of Guardant Health, Inc. (NASDAQ:GH) have been given a consensus recommendation of “Moderate Buy” by the sixteen brokerages that are presently covering the stock, Marketbeat reports. One equities research analyst has rated the stock with a hold recommendation and fifteen have issued a buy recommendation on the company. The average 12-month price target among brokers that have covered the stock in the last year is $39.67.

A number of research firms have recently issued reports on GH. Bank of America boosted their price target on shares of Guardant Health from $28.00 to $40.00 and gave the company a “buy” rating in a report on Thursday, July 18th. Craig Hallum boosted their price target on shares of Guardant Health from $28.00 to $37.00 and gave the company a “buy” rating in a report on Thursday, August 8th. UBS Group boosted their price target on shares of Guardant Health from $32.00 to $40.00 and gave the company a “buy” rating in a report on Wednesday, August 21st. JPMorgan Chase & Co. boosted their price target on shares of Guardant Health from $45.00 to $48.00 and gave the company an “overweight” rating in a report on Thursday, August 8th. Finally, Canaccord Genuity Group upped their price objective on shares of Guardant Health from $30.00 to $38.00 and gave the company a “buy” rating in a research note on Tuesday, June 4th.

Institutional Trading of Guardant Health

Large investors have recently modified their holdings of the company. Point72 Asia Singapore Pte. Ltd. bought a new stake in Guardant Health in the 2nd quarter valued at $71,000. Truist Financial Corp bought a new stake in Guardant Health in the 2nd quarter valued at $233,000. Quarry LP bought a new stake in Guardant Health in the 2nd quarter valued at $44,000. Creative Planning bought a new stake in Guardant Health in the 2nd quarter valued at $593,000. Finally, Algert Global LLC boosted its holdings in Guardant Health by 23.2% in the 2nd quarter. Algert Global LLC now owns 90,220 shares of the company’s stock valued at $2,606,000 after purchasing an additional 17,000 shares during the period. 92.60% of the stock is owned by institutional investors.

Guardant Health Stock Down 3.6 %

GH stock opened at $22.12 on Wednesday. Guardant Health has a 12 month low of $15.81 and a 12 month high of $37.04. The firm has a market cap of $2.71 billion, a PE ratio of -5.64 and a beta of 1.11. The firm has a 50 day simple moving average of $27.74 and a 200 day simple moving average of $25.26. The company has a debt-to-equity ratio of 16.70, a current ratio of 6.40 and a quick ratio of 6.07.

Guardant Health (NASDAQ:GH) last released its earnings results on Wednesday, August 7th. The company reported ($0.84) EPS for the quarter, missing the consensus estimate of ($0.74) by ($0.10). Guardant Health had a negative net margin of 76.23% and a negative return on equity of 418.21%. The business had revenue of $177.24 million for the quarter, compared to analyst estimates of $162.59 million. During the same period in the prior year, the company earned ($0.67) earnings per share. The firm’s revenue for the quarter was up 29.2% on a year-over-year basis. Equities research analysts forecast that Guardant Health will post -3.31 earnings per share for the current fiscal year.

About Guardant Health

Guardant Health, Inc, a precision oncology company, provides blood and tissue tests, data sets, and analytics in the United States and internationally. The company provides Guardant360; Guardant360 LDT; Guardant360 CDx Test; Guardant360 Response Test; Guardant360 TissueNext Test; GuardantINFINITY Test; GuardantConnect, an integrated software-based solution designed for clinical and biopharmaceutical customers to connect patients tested with assays with actionable alterations with potentially relevant clinical studies; GuardantOMNI Test for advanced stage cancer; and GuardantINFORM, an in-silico research platform for tumor evolution and treatment resistance across various biomarker-driven cancers.